Aventura Private Wealth’s Mirum Pharmaceuticals MIRM Stock Holding History

Aventura Private Wealth’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.27K	Hold	45	–	–	﹤0.01%	693
2026 Q1	$4.16K	Hold	45	–	–	﹤0.01%	677
2025 Q4	$3.56K	Hold	45	–	–	﹤0.01%	635
2025 Q3	$3.3K	Hold	45	–	–	﹤0.01%	633
2025 Q2	$2.29K	Hold	45	–	–	﹤0.01%	608
2025 Q1	$2.03K	Hold	45	–	–	﹤0.01%	606
2024 Q4	$1.86K	Buy	+45	New	+$1.88K	﹤0.01%	587

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aventura Private Wealth's MIRM Position: Q2 2026 in Review

Aventura Private Wealth held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 45 shares worth $5.27K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Aventura Private Wealth first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Aventura Private Wealth held 45 shares of Mirum Pharmaceuticals worth $5.27K as of Q2 2026.
Aventura Private Wealth left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
Mirum Pharmaceuticals made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #693 holding.
Aventura Private Wealth first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.